Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND)

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 3, 2007, Pages 413-421

  Visser, Eric ^a   Postema, Ernst ^b   Boerman, Otto ^a   Visschers, Jeroen ^a   Oyen, Wim ^a   Corstens, Frans ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Dosimetry; Gamma cameras; Nuclear imaging detectors; Scintigraphy

Indexed keywords

BLOOD DERIVATIVE;

ARTICLE; ATTENUATION; BLADDER; BONE; BONE MARROW; COMPUTER; COMPUTER PROGRAM; DOSE CALCULATION; ERROR; HALF LIFE TIME; IDL VIRTUAL MACHINE; INFORMATION PROCESSING; MACHINE; MICTURITION; NUCLEAR MEDICINE; ORGAN; PARAMETER; RADIATION DOSE; READING; RED BONE MARROW; REGION OF INTEREST PARAMETER; SCINTILLATION CAMERA; STATISTICS; WHOLE BODY SCINTISCANNING;

ALGORITHMS; COMPUTER SIMULATION; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; NUCLEAR MEDICINE; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; SOFTWARE; SOFTWARE DESIGN; TISSUE DISTRIBUTION; USER-COMPUTER INTERFACE; WHOLE-BODY COUNTING;

EID: 33847139003     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0226-z     Document Type: Article

References (21)

1. Loevinger R, Budinger T, Watson E. MIRD primer for absorbed dose calculations. New York: Society of Nuclear Medicine; 1988.
2. Stabin MG. MIRDOSE: personal computer software for internal dose asssessment in nuclear medicine. J Nucl Med 1996;37:538-46.
3. Stabin MG, Sparks RB. Olinda - PC-based software for biokinetic analysis and internal dose calculations in nuclear medicine. J Nucl Med 2003;44:103P.
4. 186Re- labeled bivatuzumab in patients with head and neck cancer. J Nucl Med 2003;44:1690-9.
5. Stabin MG, da Luz CQPL. New decay data for internal and extrernal dose assessment. Health Phys 2002;83(4):471-75.
6. International Commission on Radiological Protection. Report of the task group on reference man, ICRP publication 23. New York: Pergamon Press; 1975. pp. 89-91.
7. Shen S, DeNardo GL, Sgouros G, O'Donnell RT, DeNardo SJ. Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body. J Nucl Med 1999;40:2102-6.
8. Brown E, Hopper J, Hodges JL, Bradley B, Wennesland R, Yamauchi H. Red cell, plasma, and blood volume in the healthy women measured by radiochromium cell-labeling and hematocrit. J Clin Invest 1962;41:2182-90.
9. Wennesland R, Brown E, Hopper J, Hodges JL, Guttentag OE, Scott KG, et al. Red cell, plasma and blood volume in healthy men measured by radiochromium (Cr51) cell tagging and hematocrit: influence of age, somatotype and habits of physical activity on the variance after regression of volumes to height and weight combined. J Clin Invest 1959;38:1065-77.
10. Thomas SR, Maxon HR, Kereiakes JG. In vivo quantitation of lesion radioactivity using external counting methods. Med Phys 1976;3:253-5.
11. Buijs WCAM, Siegel JA, Boerman OC, Corstens FHM. Absolute organ activity estimated by five different methods of background correction. J Nucl Med 1998;39:2167-72.
12. Snyder WS, Ford MR, Warner GG, Watson SB. 'S', Absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD pamphlet 11. New York, NY: Society of Nuclear Medicine; 1975.
13. Weber D, Eckerman KF, Dillman LT, Ryman J. MIRD: radionuclide data and decay schemes. New York: Society of Nuclear Medicine; 1989.
14. Eckerman KF, Stabin MG. Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions. Health Phys 2000;78:199-214.
15. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med 1993;34:689-94.
16. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. MIRD pamplet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999;40:37S-61S.
17. Erwin WD, Groch MW, Macey DJ, DeNardo GL, DeNardo SJ, Shen S. A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy. Nucl Med Biol 1996;23:525-32.
18. Liu A, Williams LE, Lopatin G, Yamauchi DM, Wong JY, Raubitschek AA. A radionuclide therapy treatment planning and dose estimation system. J Nucl Med 1999;40:1151-3.
19. 131I. J Nucl Med 2002;43:972-82.
20. McKay E. A software tool for specifying voxel models for dosimetry estimation. Cancer Biother Radiopharm 2003;18: 61-9.
21. Glatting G, Landmann M, Kull Th, Wunderlich A, Blumstein NM, Buck AK, et al. Internal radionuclide therapy: the ULMDOS software for treatment planning. Med Phys 2005;32:2399-405.